SAREPTA THERAPEUTICS, INC. Impairment of Real Estate
SAREPTA THERAPEUTICS, INC. (SRPT) reported Impairment of Real Estate of $1.45 million for the 404-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfRealEstate · last filed 2014-05-08
- SAREPTA THERAPEUTICS, INC. impairment of real estate for the quarter ending 2012-12-31 was $0.00.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for the quarter ending 2012-06-30 was $0.00.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for the quarter ending 2012-03-31 was $0.00.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for fiscal 2011 was $109.00K, a 72.75% decline from fiscal 2010.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for fiscal 2010 was $400.00K, a 212.50% increase from fiscal 2009.
- SAREPTA THERAPEUTICS, INC. impairment of real estate for fiscal 2009 was $128.00K.
| Period end | Impairment of Real Estate 3 month | Impairment of Real Estate 6 month | Impairment of Real Estate 9 month | Impairment of Real Estate 12 month | Impairment of Real Estate 12 month as first filed | Impairment of Real Estate 371 month | Impairment of Real Estate 374 month | Impairment of Real Estate 377 month | Impairment of Real Estate 380 month | Impairment of Real Estate 383 month | Impairment of Real Estate 386 month | Impairment of Real Estate 389 month | Impairment of Real Estate 392 month | Impairment of Real Estate 395 month | Impairment of Real Estate 398 month | Impairment of Real Estate 401 month | Impairment of Real Estate 404 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $1.45M 10-Q · filed 2014-05-08 | ||||||||||||||||
| 2013-12-31 | $1.45M 10-K · filed 2014-03-03 | ||||||||||||||||
| 2013-09-30 | $1.45M 10-Q · filed 2013-11-12 | ||||||||||||||||
| 2013-06-30 | $1.45M 10-Q · filed 2013-08-08 | ||||||||||||||||
| 2013-03-31 | $1.45M 10-Q · filed 2013-05-09 | ||||||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $0.00 derived: sum of 3 quarters · filed 2013-03-15 | $0.00 10-K · filed 2013-03-15 | $1.45M 10-K · filed 2013-03-15 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $0.00 10-Q · filed 2012-11-07 | $0.00 derived: sum of 4 quarters · filed 2014-03-03 | $1.45M 10-Q · filed 2012-11-07 | ||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $0.00 10-Q · filed 2012-08-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | $109.00K derived: sum of 4 quarters · filed 2014-03-03 | $1.45M 10-Q · filed 2012-08-07 | ||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $109.00K derived: sum of 3 quarters · filed 2014-03-03 | $109.00K derived: sum of 4 quarters · filed 2014-03-03 | $1.45M 10-Q · filed 2012-05-10 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $109.00K derived: sum of 2 quarters · filed 2014-03-03 | $109.00K derived: sum of 3 quarters · filed 2014-03-03 | $109.00K 10-K · filed 2014-03-03 | $1.45M 10-K · filed 2012-03-13 | ||||||||||||
| 2011-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $109.00K derived: sum of 2 quarters · filed 2012-11-07 | $109.00K 10-Q · filed 2012-11-07 | $116.00K derived: sum of 4 quarters · filed 2014-03-03 | $1.45M 10-Q · filed 2011-11-08 | ||||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $0.00 10-Q · filed 2012-08-07 | $7.00K derived: sum of 3 quarters · filed 2014-03-03 | $1.34M 10-Q · filed 2011-08-08 | |||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | $7.00K derived: sum of 2 quarters · filed 2014-03-03 | |||||||||||||||
| 2010-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $400.00K 10-K · filed 2014-03-03 | $408.00K 10-K · filed 2012-03-13 | ||||||||||||||
| 2010-09-30 | $393.00K 10-Q · filed 2011-11-08 | ||||||||||||||||
| 2009-12-31 | $128.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |